Cargando…

Scaling-Down Mass Ivermectin Treatment for Onchocerciasis Elimination: Modeling the Impact of the Geographical Unit for Decision Making

BACKGROUND: Due to spatial heterogeneity in onchocerciasis transmission, the duration of ivermectin mass drug administration (MDA) required for eliminating onchocerciasis will vary within endemic areas and the occurrence of transmission “hotspots” is inevitable. The geographical scale at which stop-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stolk, Wilma A, Blok, David J, Hamley, Jonathan I D, Cantey, Paul T, de Vlas, Sake J, Walker, Martin, Basáñez, María-Gloria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201558/ https://www.ncbi.nlm.nih.gov/pubmed/33909070 http://dx.doi.org/10.1093/cid/ciab238

Ejemplares similares

Structural Uncertainty in Onchocerciasis Transmission Models Influences the Estimation of Elimination Thresholds and Selection of Age Groups for Seromonitoring
por: Hamley, Jonathan I D, et al.
Publicado: (2020)

Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis
por: Stolk, Wilma A., et al.
Publicado: (2015)

How Can Onchocerciasis Elimination in Africa Be Accelerated? Modeling the Impact of Increased Ivermectin Treatment Frequency and Complementary Vector Control
por: Verver, Suzanne, et al.
Publicado: (2018)

What does the COVID-19 pandemic mean for the next decade of onchocerciasis control and elimination?
por: Hamley, Jonathan I D, et al.
Publicado: (2021)

Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014)

Modelling Anti-Ov16 IgG4 Antibody Prevalence as an Indicator for Evaluation and Decision Making in Onchocerciasis Elimination Programmes
por: Lont, Yvonne L., et al.
Publicado: (2017)

Predictive Value of Ov16 Antibody Prevalence in Different Subpopulations for Elimination of African Onchocerciasis
por: Coffeng, Luc E, et al.
Publicado: (2019)

African Program for Onchocerciasis Control 1995–2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases
por: Krotneva, Stanimira P., et al.
Publicado: (2015)

Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2022)

Correction: Onchocerciasis: Target product profiles of in vitro diagnostics to support onchocerciasis elimination mapping and mass drug administration stopping decisions
por: Biamonte, Marco A., et al.
Publicado: (2023)

The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages
por: de Vos, Anneke S., et al.
Publicado: (2021)

Elimination or Resurgence: Modelling Lymphatic Filariasis After Reaching the 1% Microfilaremia Prevalence Threshold
por: Prada, Joaquin M, et al.
Publicado: (2020)

Modelling for policy: The five principles of the Neglected Tropical Diseases Modelling Consortium
por: Behrend, Matthew R., et al.
Publicado: (2020)

Feasibility of Onchocerciasis Elimination Using a “Test-and-not-treat” Strategy in Loa loa Co-endemic Areas
por: Blok, David J, et al.
Publicado: (2020)

Modelling the elimination of river blindness using long-term epidemiological and programmatic data from Mali and Senegal
por: Walker, Martin, et al.
Publicado: (2017)

Modelling exposure heterogeneity and density dependence in onchocerciasis using a novel individual-based transmission model, EPIONCHO-IBM: Implications for elimination and data needs
por: Hamley, Jonathan I. D., et al.
Publicado: (2019)

Diagnostics for onchocerciasis in the era of elimination
por: Unnasch, Thomas R, et al.
Publicado: (2018)

The effect of assortative mixing on stability of low helminth transmission levels and on the impact of mass drug administration: Model explorations for onchocerciasis
por: de Vos, Anneke S., et al.
Publicado: (2018)

Uncertainty Surrounding Projections of the Long-Term Impact of Ivermectin Treatment on Human Onchocerciasis
por: Turner, Hugo C., et al.
Publicado: (2013)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin
por: Wilson, Nana O., et al.
Publicado: (2016)

The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models
por: Stolk, Wilma A, et al.
Publicado: (2018)

Onchocerciasis: The Pre-control Association between Prevalence of Palpable Nodules and Skin Microfilariae
por: Coffeng, Luc E., et al.
Publicado: (2013)

Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling
por: Stolk, Wilma A, et al.
Publicado: (2006)

Modelling the health and economic impacts of the elimination of river blindness (onchocerciasis) in Africa
por: Kim, Young Eun, et al.
Publicado: (2017)

Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results
por: Tekle, Afework H., et al.
Publicado: (2016)

Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2018)

The Cost of Annual versus Biannual Community-Directed Treatment of Onchocerciasis with Ivermectin: Ghana as a Case Study
por: Turner, Hugo C., et al.
Publicado: (2013)

Elimination of onchocerciasis in Africa by 2025: an ambitious target requires ambitious interventions
por: Colebunders, Robert, et al.
Publicado: (2019)

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
por: Vieira, Juan Carlos, et al.
Publicado: (2007)

How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021)

Antibody and Antigen Prevalence as Indicators of Ongoing Transmission or Elimination of Visceral Leishmaniasis: A Modeling Study
por: Coffeng, Luc E, et al.
Publicado: (2021)

The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment
por: Noma, Mounkaila, et al.
Publicado: (2014)

Can mass drug administration of moxidectin accelerate onchocerciasis elimination in Africa?
por: Kura, Klodeta, et al.
Publicado: (2023)

Global elimination of leprosy by 2020: are we
por: Blok, David J., et al.
Publicado: (2015)

Reaching the London Declaration on Neglected Tropical Diseases Goals for Onchocerciasis: An Economic Evaluation of Increasing the Frequency of Ivermectin Treatment in Africa
por: Turner, Hugo C., et al.
Publicado: (2014)

Impact of Different Sampling Schemes for Decision Making in Soil-Transmitted Helminthiasis Control Programs
por: Coffeng, Luc E, et al.
Publicado: (2020)

Onchocerciasis: shifting the target from control to elimination requires a new first-step—elimination mapping
por: Rebollo, Maria P, et al.
Publicado: (2018)

From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes
por: Colebunders, Robert, et al.
Publicado: (2019)

Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas
por: Niamsi-Emalio, Yannick, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u9jn20uo17sa084mjd2rrdr7h2